Closing the global vaccine equity gap: equitably distributed manufacturing

Victor J. Dzau; Celynne A. Balatbat; Anaeze C. Offodile

doi:10.1016/S0140-6736(22)00793-0

Closing the global vaccine equity gap: equitably distributed manufacturing

Victor J. Dzau, Celynne A. Balatbat, Anaeze C. Offodile

Plastic Surgery

Research output: Contribution to journal › Comment/debate › peer-review

13 Scopus citations

Original language	English (US)
Pages (from-to)	1924-1926
Number of pages	3
Journal	The Lancet
Volume	399
Issue number	10339
DOIs	https://doi.org/10.1016/S0140-6736(22)00793-0
State	Published - May 21 2022

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/S0140-6736(22)00793-0

Cite this

@article{c37f6d37f725455385567daba7744d67,

title = "Closing the global vaccine equity gap: equitably distributed manufacturing",

author = "Dzau, {Victor J.} and Balatbat, {Celynne A.} and Offodile, {Anaeze C.}",

note = "Funding Information: VJD will be a co-chair of the World Economic Forum's Collaborative on Equitable Vaccine Manufacturing Capacity. ACO reports research funding from Blue Cross Blue Shield, Rising Tide Foundation for Clinical Cancer Research, Sister Institution Network Fund, and the US National Academy of Medicine and honoraria from the Departments of Surgery at Indiana University and the University of Tennessee, USA, all of which are unrelated to the topic of this Comment. CAB declares no competing interests.",

year = "2022",

month = may,

day = "21",

doi = "10.1016/S0140-6736(22)00793-0",

language = "English (US)",

volume = "399",

pages = "1924--1926",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "10339",

}

TY - JOUR

T1 - Closing the global vaccine equity gap

T2 - equitably distributed manufacturing

AU - Dzau, Victor J.

AU - Balatbat, Celynne A.

AU - Offodile, Anaeze C.

N1 - Funding Information: VJD will be a co-chair of the World Economic Forum's Collaborative on Equitable Vaccine Manufacturing Capacity. ACO reports research funding from Blue Cross Blue Shield, Rising Tide Foundation for Clinical Cancer Research, Sister Institution Network Fund, and the US National Academy of Medicine and honoraria from the Departments of Surgery at Indiana University and the University of Tennessee, USA, all of which are unrelated to the topic of this Comment. CAB declares no competing interests.

PY - 2022/5/21

Y1 - 2022/5/21

UR - http://www.scopus.com/inward/record.url?scp=85130352163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85130352163&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(22)00793-0

DO - 10.1016/S0140-6736(22)00793-0

M3 - Comment/debate

C2 - 35533706

AN - SCOPUS:85130352163

SN - 0140-6736

VL - 399

SP - 1924

EP - 1926

JO - The Lancet

JF - The Lancet

IS - 10339

ER -

Closing the global vaccine equity gap: equitably distributed manufacturing

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this